Shares of Amdocs Limited (NASDAQ:DOX – Get Free Report) have been given an average rating of “Hold” by the six research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating on the company. The average 1-year target price among analysts that have covered the stock in the last year is $86.6667.
Several research firms have weighed in on DOX. Weiss Ratings reiterated a “hold (c-)” rating on shares of Amdocs in a research report on Friday, May 8th. Cfra cut shares of Amdocs to a “sell” rating in a research report on Thursday, May 14th. Stifel Nicolaus lowered their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Finally, Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th.
Check Out Our Latest Report on Amdocs
Amdocs Trading Down 0.6%
Amdocs (NASDAQ:DOX – Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. The firm had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. Amdocs had a net margin of 11.81% and a return on equity of 19.77%. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.78 earnings per share. On average, research analysts predict that Amdocs will post 6.56 EPS for the current fiscal year.
Amdocs Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.569 per share. This represents a $2.28 annualized dividend and a yield of 3.9%. The ex-dividend date is Tuesday, June 30th. Amdocs’s payout ratio is presently 45.60%.
Hedge Funds Weigh In On Amdocs
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Scotia Capital Inc. grew its position in Amdocs by 3.5% during the 3rd quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after purchasing an additional 145 shares in the last quarter. CENTRAL TRUST Co boosted its stake in shares of Amdocs by 6.1% during the 3rd quarter. CENTRAL TRUST Co now owns 2,741 shares of the technology company’s stock valued at $225,000 after buying an additional 158 shares during the period. WealthCollab LLC boosted its stake in shares of Amdocs by 94.5% during the 3rd quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after buying an additional 173 shares during the period. Rossby Financial LCC boosted its stake in shares of Amdocs by 39.3% during the 3rd quarter. Rossby Financial LCC now owns 620 shares of the technology company’s stock valued at $50,000 after buying an additional 175 shares during the period. Finally, Blair William & Co. IL boosted its stake in shares of Amdocs by 5.5% during the 3rd quarter. Blair William & Co. IL now owns 3,393 shares of the technology company’s stock valued at $278,000 after buying an additional 177 shares during the period. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Featured Articles
- Five stocks we like better than Amdocs
- Uranium Energy Corp Melts Down—Nuclear Opportunity at Hand
- Optical Cable Corporation: Strong Earnings, But Hurdles Remain
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
